Everett Neville is VP at Cigna Group (CI). They have made 16 open-market trades across 2 companies since 2016, most recently 2026-09-03.
CIK 0001641142
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESRX | 31,049 | $2.9M |
| CI | 5,053 | $1.5M |
| Total | $4.4M |
Shares reported on the most recent Form 4, priced at the 2026-09-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CI | SELL · 10b5-1 | 2026-09-03 | 2026-09-08 | $284.05 | $175K | -1.4% | +0.6% | — |
| CI | SELL | 2026-03-02 | 2026-03-03 | $288.91 | $497K | -4.9% | -3.9% | -2.4% |
| CI | SELL · 10b5-1 | 2023-07-19 | 2023-07-21 | $295.21 | $7.8M | +2.2% | -4.0% | +5.8% |
| CI | SELL · 10b5-1 | 2023-07-10 | 2023-07-12 | $277.61 | $259K | +8.5% | +7.6% | +8.4% |
| CI | SELL | 2023-03-10 | 2023-03-14 | $271.67 | $1.6M | -3.2% | -1.9% | -0.7% |
| CI | SELL | 2023-03-02 | 2023-03-03 | $289.00 | $131K | -5.6% | -8.5% | -11.5% |
| CI | SELL | 2023-02-27 | 2023-02-28 | $294.06 | $1.0M | -4.6% | -12.1% | -16.0% |
| CI | SELL | 2022-08-01 | 2022-08-03 | $273.98 | $494K | +3.6% | +2.5% | +15.9% |
| CI | SELL | 2022-07-07 | 2022-07-11 | $275.00 | $1.4M | -4.6% | +2.8% | +2.3% |
| CI | SELL | 2022-04-06 | 2022-04-08 | $250.00 | $250K | +2.6% | +1.3% | +6.9% |
| CI | SELL | 2022-03-02 | 2022-03-03 | $239.00 | $69K | -0.5% | +3.4% | +12.9% |
| CI | SELL | 2022-02-28 | 2022-03-01 | $228.70 | $123K | -5.1% | +0.3% | +12.3% |
| CI | SELL · 10b5-1 | 2022-01-11 | 2022-01-13 | $240.00 | $42K | -2.3% | -6.0% | +8.1% |
| CI | SELL | 2022-01-03 | 2022-01-05 | $229.49 | $1.1M | +3.1% | -4.9% | +5.3% |
| ESRX | SELL | 2018-03-01 | 2018-03-02 | $75.26 | $737K | +3.2% | -8.7% | +2.0% |
| ESRX | SELL | 2017-08-23 | 2017-08-25 | $61.48 | $143K | +2.1% | +2.3% | +0.2% |
| ESRX | SELL | 2017-03-01 | 2017-03-02 | $70.16 | $330K | -7.3% | -8.6% | -17.1% |
| ESRX | SELL | 2017-01-03 | 2017-01-05 | $69.41 | $156K | +2.6% | -4.8% | -6.7% |
| ESRX | SELL | 2016-05-10 | 2016-05-11 | $74.11 | $59K | -0.9% | +3.2% | +3.9% |
| ESRX | SELL | 2016-02-29 | 2016-03-01 | $71.00 | $307K | -1.9% | -4.1% | +5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.